Sign in

    Manoj Eradath

    Vice President and Equity Analyst at Jefferies LLC

    Manoj Eradath is a Vice President and Equity Analyst at Jefferies LLC, specializing in research on the technology sector, with a particular focus on companies operating in the IT services and consulting domains. Throughout his career, he has covered major firms such as Infosys, Tata Consultancy Services, and Wipro, delivering analysis influential to institutional investors, though specific performance rankings or TipRanks data are not publicly available. Eradath began his professional financial career in the mid-2010s and has held his current position at Jefferies since at least 2021, having previously gained experience at other financial institutions in related analytical roles. He holds FINRA registrations with Series 7 and Series 63 licenses, underscoring his professional qualifications and regulatory standing.

    Manoj Eradath's questions to Zymeworks (ZYME) leadership

    Manoj Eradath's questions to Zymeworks (ZYME) leadership • Q4 2024

    Question

    Manoj Eradath, on behalf of Akash Tewari, asked about the delay in the HERIZON-GEA-01 trial readout, questioning if it was due to enrollment speed or event rates, and inquired about potential patient selection bias regarding PD-1 status.

    Answer

    Chair and CEO Kenneth Galbraith declined to speculate on the trial specifics, referring the question back to their partner Jazz Pharmaceuticals, who provided an update on the guidance and rationale during their own recent earnings call.

    Ask Fintool Equity Research AI